Validation pour Ingenuity287

vers la météo de la validation par utilisateur

Ingenuity287

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 0 - PMID ?

In pancreatic islets from male Zucker diabetic fatty SP , oral administration of NODE ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of SP NODE mRNA .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A1">Analyse 1

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A2">Analyse 2

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A3">Analyse 3

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A4">Analyse 4

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A5">Analyse 5

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A6">Analyse 6

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A7">Analyse 7

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A8">Analyse 8

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A9">Analyse 9

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A10">Analyse 10

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A11">Analyse 11

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A12">Analyse 12

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A13">Analyse 13

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A14">Analyse 14

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A15">Analyse 15

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A16">Analyse 16

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A17">Analyse 17

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A18">Analyse 18

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A19">Analyse 19

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A20">Analyse 20

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A21">Analyse 21

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A22">Analyse 22

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A23">Analyse 23

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A24">Analyse 24

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A25">Analyse 25

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A26">Analyse 26

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A27">Analyse 27

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A28">Analyse 28

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A29">Analyse 29

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A30">Analyse 30

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A31">Analyse 31

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A32">Analyse 32

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A33">Analyse 33

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A34">Analyse 34

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A35">Analyse 35

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A36">Analyse 36

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A37">Analyse 37

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A38">Analyse 38

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A39">Analyse 39

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A40">Analyse 40

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A41">Analyse 41

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A42">Analyse 42

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A43">Analyse 43

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A44">Analyse 44

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A45">Analyse 45

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A46">Analyse 46

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A47">Analyse 47

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A48">Analyse 48

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A49">Analyse 49

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A50">Analyse 50

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A51">Analyse 51

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A52">Analyse 52

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A53">Analyse 53

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A54">Analyse 54

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A55">Analyse 55

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A56">Analyse 56

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A57">Analyse 57

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A58">Analyse 58

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A59">Analyse 59

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A60">Analyse 60

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A61">Analyse 61

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A62">Analyse 62

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A63">Analyse 63

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A64">Analyse 64

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A65">Analyse 65

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A66">Analyse 66

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A67">Analyse 67

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A68">Analyse 68

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A69">Analyse 69

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A70">Analyse 70

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A71">Analyse 71

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A72">Analyse 72

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A73">Analyse 73

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A74">Analyse 74

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A75">Analyse 75

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A76">Analyse 76

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A77">Analyse 77

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A78">Analyse 78

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A79">Analyse 79

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A80">Analyse 80

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A81">Analyse 81

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A82">Analyse 82

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A83">Analyse 83

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A84">Analyse 84

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A85">Analyse 85

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A86">Analyse 86

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A87">Analyse 87

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A88">Analyse 88

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A89">Analyse 89

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A90">Analyse 90

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A91">Analyse 91

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A92">Analyse 92

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A93">Analyse 93

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A94">Analyse 94

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A95">Analyse 95

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A96">Analyse 96

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A97">Analyse 97

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A98">Analyse 98

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A99">Analyse 99

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A100">Analyse 100

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A101">Analyse 101

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A102">Analyse 102

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A103">Analyse 103

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A104">Analyse 104

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A105">Analyse 105

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A106">Analyse 106

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A107">Analyse 107

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A108">Analyse 108

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A109">Analyse 109

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A110">Analyse 110

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A111">Analyse 111

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A112">Analyse 112

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A113">Analyse 113

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A114">Analyse 114

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A115">Analyse 115

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A116">Analyse 116

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A117">Analyse 117

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A118">Analyse 118

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A119">Analyse 119

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A120">Analyse 120

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A121">Analyse 121

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A122">Analyse 122

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A123">Analyse 123

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A124">Analyse 124

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A125">Analyse 125

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A126">Analyse 126

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A127">Analyse 127

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A128">Analyse 128

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A129">Analyse 129

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A130">Analyse 130

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A131">Analyse 131

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A132">Analyse 132

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A133">Analyse 133

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A134">Analyse 134

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A135">Analyse 135

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A136">Analyse 136

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A137">Analyse 137

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A138">Analyse 138

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A139">Analyse 139

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A140">Analyse 140

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A141">Analyse 141

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A142">Analyse 142

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A143">Analyse 143

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A144">Analyse 144

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A145">Analyse 145

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A146">Analyse 146

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A147">Analyse 147

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A148">Analyse 148

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A149">Analyse 149

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A150">Analyse 150

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A151">Analyse 151

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A152">Analyse 152

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A153">Analyse 153

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A154">Analyse 154

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A155">Analyse 155

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A156">Analyse 156

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A157">Analyse 157

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A158">Analyse 158

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A159">Analyse 159

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A160">Analyse 160

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A161">Analyse 161

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A162">Analyse 162

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A163">Analyse 163

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A164">Analyse 164

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A165">Analyse 165

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A166">Analyse 166

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A167">Analyse 167

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A168">Analyse 168

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A169">Analyse 169

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A170">Analyse 170

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A171">Analyse 171

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A172">Analyse 172

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A173">Analyse 173

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A174">Analyse 174

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A175">Analyse 175

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A176">Analyse 176

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A177">Analyse 177

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A178">Analyse 178

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A179">Analyse 179

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A180">Analyse 180

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A181">Analyse 181

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A182">Analyse 182

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A183">Analyse 183

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A184">Analyse 184

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A185">Analyse 185

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A186">Analyse 186

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A187">Analyse 187

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A188">Analyse 188

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A189">Analyse 189

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A190">Analyse 190

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A191">Analyse 191

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A192">Analyse 192

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A193">Analyse 193

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A194">Analyse 194

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A195">Analyse 195

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A196">Analyse 196

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A197">Analyse 197

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A198">Analyse 198

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A199">Analyse 199

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A200">Analyse 200

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A201">Analyse 201

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A202">Analyse 202

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A203">Analyse 203

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A204">Analyse 204

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A205">Analyse 205

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A206">Analyse 206

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A207">Analyse 207

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A208">Analyse 208

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A209">Analyse 209

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A210">Analyse 210

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A211">Analyse 211

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A212">Analyse 212

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A213">Analyse 213

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A214">Analyse 214

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A215">Analyse 215

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A216">Analyse 216

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A217">Analyse 217

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A218">Analyse 218

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A219">Analyse 219

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A220">Analyse 220

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A221">Analyse 221

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A222">Analyse 222

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A223">Analyse 223

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A224">Analyse 224

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A225">Analyse 225

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A226">Analyse 226

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A227">Analyse 227

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A228">Analyse 228

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A229">Analyse 229

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A230">Analyse 230

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A231">Analyse 231

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A232">Analyse 232

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A233">Analyse 233

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A234">Analyse 234

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A235">Analyse 235

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A236">Analyse 236

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A237">Analyse 237

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A238">Analyse 238

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A239">Analyse 239

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)